CHS-006 (anti-TIGIT)
CHS-006-01
Phase 1 small_molecule terminated
Quick answer
CHS-006 (anti-TIGIT) for Advanced Solid Tumor is a Phase 1 program (small_molecule) at Coherus Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Coherus Oncology
- Indication
- Advanced Solid Tumor
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated